Kowa Company, Ltd. - Product Pipeline Review - 2016

Date: August 17, 2016
Pages: 53
Price:
US$ 1,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: K59A223A163EN
Leaflet:

Download PDF Leaflet

Kowa Company, Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Kowa Company, Ltd. - Product Pipeline Review - 2016’, provides an overview of the Kowa Company, Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kowa Company, Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope
  • The report provides a snapshot of the pipeline therapeutic landscape of Kowa Company, Ltd.
  • The report provides overview of Kowa Company, Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Kowa Company, Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Kowa Company, Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Kowa Company, Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Kowa Company, Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Kowa Company, Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Kowa Company, Ltd. Snapshot
Kowa Company, Ltd. Overview
Key Information
Key Facts
Kowa Company, Ltd. - Research and Development Overview
Key Therapeutic Areas
Kowa Company, Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Kowa Company, Ltd. - Pipeline Products Glance
Kowa Company, Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Kowa Company, Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Kowa Company, Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Kowa Company, Ltd. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Kowa Company, Ltd. - Drug Profiles
pemafibrate
Product Description
Mechanism of Action
R&D Progress
anagliptin
Product Description
Mechanism of Action
R&D Progress
peretinoin
Product Description
Mechanism of Action
R&D Progress
K-134
Product Description
Mechanism of Action
R&D Progress
ripasudil
Product Description
Mechanism of Action
R&D Progress
epirubicin hydrochloride
Product Description
Mechanism of Action
R&D Progress
K-312
Product Description
Mechanism of Action
R&D Progress
pitavastatin NP
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Agonize LXRB for Atherosclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Acyl-Coenzyme A for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Oncology
Product Description
Mechanism of Action
R&D Progress
K-163SZ
Product Description
Mechanism of Action
R&D Progress
Kowa Company, Ltd. - Pipeline Analysis
Kowa Company, Ltd. - Pipeline Products by Target
Kowa Company, Ltd. - Pipeline Products by Route of Administration
Kowa Company, Ltd. - Pipeline Products by Molecule Type
Kowa Company, Ltd. - Pipeline Products by Mechanism of Action
Kowa Company, Ltd. - Recent Pipeline Updates
Kowa Company, Ltd. - Dormant Projects
Kowa Company, Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
pitavastatin CR
Kowa Company, Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Kowa Company, Ltd., Key Information
Kowa Company, Ltd., Key Facts
Kowa Company, Ltd. - Pipeline by Indication, 2016
Kowa Company, Ltd. - Pipeline by Stage of Development, 2016
Kowa Company, Ltd. - Monotherapy Products in Pipeline, 2016
Kowa Company, Ltd. - Partnered Products in Pipeline, 2016
Kowa Company, Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
Kowa Company, Ltd. - Pre-Registration, 2016
Kowa Company, Ltd. - Phase III, 2016
Kowa Company, Ltd. - Phase II, 2016
Kowa Company, Ltd. - Phase I, 2016
Kowa Company, Ltd. - Preclinical, 2016
Kowa Company, Ltd. - Discovery, 2016
Kowa Company, Ltd. - Unknown, 2016
Kowa Company, Ltd. - Pipeline by Target, 2016
Kowa Company, Ltd. - Pipeline by Route of Administration, 2016
Kowa Company, Ltd. - Pipeline by Molecule Type, 2016
Kowa Company, Ltd. - Pipeline Products by Mechanism of Action, 2016
Kowa Company, Ltd. - Recent Pipeline Updates, 2016
Kowa Company, Ltd. - Dormant Developmental Projects,2016
Kowa Company, Ltd. - Discontinued Pipeline Products, 2016
Kowa Company, Ltd., Other Locations
Kowa Company, Ltd., Subsidiaries

LIST OF FIGURES

Kowa Company, Ltd. - Pipeline by Top 10 Indication, 2016
Kowa Company, Ltd. - Pipeline by Stage of Development, 2016
Kowa Company, Ltd. - Monotherapy Products in Pipeline, 2016
Kowa Company, Ltd. - Partnered Products in Pipeline, 2016
Kowa Company, Ltd. - Pipeline by Top 10 Target, 2016
Kowa Company, Ltd. - Pipeline by Route of Administration, 2016
Kowa Company, Ltd. - Pipeline by Molecule Type, 2016
Kowa Company, Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Skip to top


Ask Your Question

Kowa Company, Ltd. - Product Pipeline Review - 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: